The global burn care market size was estimated at USD 1.88 billion in 2018. It is anticipated to expand at CAGR of 6.8% during the forecast period. Increasing incidence of burn-related injuries is anticipated to drive the growth. Rising demand for minimally invasive procedures and treatments to improve cosmetic appeal is a key contributor to market growth.
Moreover, rising concern regarding aesthetic appearance among patients is a major factor attributed to the rising demand for the products available in the market. Furthermore, associated advantages with the use of biologics to treat wound, such as accelerated wound healing, cost efficiency, and shorter length of hospital stay are expected to drive growth in near future.
Rising demand for skin grafts is also a major growth contributor to burn care market. Skin grafts are majorly used on partial and full thickness burns and play an important role in treatment of burn injuries. Skin grafts allow excellent epithelialization due to the presence of basement membrane and show larger control over scaffold composition. They also have advantages over other dressing materials, as they do not require frequent changing. Due to the aforementioned benefits, there is high demand for skin grafts, which is expected to drive the growth.
Increasing awareness level among people regarding the availability of various treatment options for burn care management is anticipated to boost market growth. Rising disposable income in developing economies coupled with willingness to opt for new and advanced wound care products, is anticipated to impel the demand.
Different treatment options include advanced dressings, traditional products, biologics, and other pressure therapies. Advanced dressings include alginate dressings, hydrogel dressings, foam dressings, hydrocolloid dressings, collagen dressings, and others. Biologics segment includes skin grafts, whereas traditional products include tapes and regular dressings.
Advance dressing held a dominant market share in 2018, owing to the higher penetration in developed countries. The benefits associated with the use of these products such as ease of use, lesser recovery time, and cost efficiency are contributing to the growing adoption.
Collagen dressings held the dominant market share in the advanced dressing segment in 2018, due to its ability to lower the risk of infection in the wound. It helps minimize irritation, keeps the wound moist and soft and is available in a variety of shapes and sizes. Thus, the aforementioned benefits with its usage are expected to fuel the growth. Other available options in advance dressing such as alginate, hydrogel, foam, and film dressing, of which, hydrogel segment is anticipated to witness significant growth over the forecast period due to rising awareness among patients and healthcare professionals.
Biologics, such as skin grafts and substitutes, bio-membrane, and growth factors such as interleukin-8 and fibroblast are expected to display lucrative growth in the forthcoming years. Biologic dressings prevent heat loss, water loss, protein and electrolyte loss, and contamination. Advancements in technology for the development of skin substitutes such as collagen-synthetic laminates and tissue culture-derived membranes are on a rise. The abovementioned factors are anticipated to drive the market.
The incidence of minor burn injuries is more as compared to partial and full-thickness injuries. In terms of revenue, the full thickness injuries held the dominant share of the overall market as the treatment requires long-term observation care.
Minor wound segment is expected to showcase the fastest growth over the next few years as these wounds have the potential to develop into acute and chronic wounds. To treat this condition, clinicians require a thorough understanding for performing outside interventions for proper healing of wounds. This increases the number of visits of a patient to the clinician’s office.
Minor burns can be treated with advanced or traditional dressing products and can recover in less time. Collagen sheets are more useful in treating minor wounds. These sheets are non-inflammatory and facilitate fibroblast migration, which helps in wound healing. Some of the commonly known collagen sheets are Xenostat manufactured by Helix Pharma, Kollagen-M, and NeuSkin by Eucare Pharmaceuticals Pvt. Ltd.
Chronic wounds include partial thickness and full thickness injuries. These conditions take longer time for healing and cover more than 15% of the body. These wounds can be caused by various external factors such as electricity, radiation, friction, chemicals, respiratory, and thermal objects. Skin grafts are used to treat partial and full-thickness injuries. Skin grafts offer more intact extracellular matrix, which aids in faster healing of wounds.
Thermal burns held the largest market share in 2018 owing to rising incidence of fire-related injuries. Thermal burns include the burns caused by fires, steam, flash, hot objects, and hot liquids. According to the American Burn Association (ABA), in 2018, fire was responsible for 43% of total admissions to burn centers in U.S. Moreover, rising government efforts to create awareness through campaigns such as the Burn Awareness Week organized by American Burn Association, BBA National Burns Awareness Days by British Burn Association will further fuel the segment growth.
The others segment is expected to witness lucrative growth over the forecast period. It includes injuries caused due to friction, abuse, and other causes. Friction burns are caused due to abrasions owing to the skin rubbing against any hard surface. The incidence is high, but majority of these injuries are minor and patients do not visit hospitals for their treatment.
According to the American Society for Radiation Oncology, around 95% of patients undergoing radiation therapy suffer from some degree of radiodermatitis. Among these, 85% of the patients experience severe-to-moderate radiodermatitis. The severity depends on the volume of tissues irradiated, location, total radiation dose received, body surface area treated, and duration for which radiation was administered. Thus, this segment is anticipated to register a CAGR of 7.4% during forecast period.
Hospitals held the largest market share in 2018, due to increasing incidence of partial and full-thickness injuries. The most commonly used products are from MNC brands like Johnson & Johnson, Smith & Nephew, and 3M. Majority of these injuries are of partial or full thickness in nature, requiring hospital administration at an earlier stage. This is contributing to the segment growth. Hospitals are further classified into inpatient and outpatient care facilities. Outpatient care units held the dominant market share in 2018 as majority of cases are of partial injuries.
The clinic segment is expected to witness steady growth in near future owing to growing penetration of standalone clinics in metro cities. Clinics offer traditional and advanced wound care products on a large scale. The higher penetration rates are expected to be responsible for the rising revenue share of this segment during the forecast period.
The others segment includes home care and long-term care centers. This segment is anticipated to exhibit lucrative growth in the forthcoming years. Increased awareness pertaining to the available treatment options and concern for personalized treatment is contributing to the growth of home care settings.
North America led the market in 2018, attributed to the shift from traditional products to the advanced wound dressing products. Rising concern regarding aesthetic appearance and demand for minimally invasive cosmetic surgeries is anticipated to positively influence the regional demand over the forecast period.
According to statistics published by the American Society of Plastic Surgeons, in 2017, around 17.5 million minimally invasive and surgical cosmetic procedures were performed in the U.S. and the number is expected to increase over the forecast period. Thus, rising penetration of cosmetic procedures is considered to be one of the key contributing factors for the rising demand of biologics in the region.
The presence of well-established healthcare facilities, favorable reimbursement policies, and availability of advanced therapies are some of the key contributing factors for the industry growth in developing economies such as India, China, and Brazil. In addition, adoption of technologically advanced surgeries such as reconstructive burn surgery is also contributing to market growth.
Asia Pacific is anticipated to witness lucrative CAGR in the forthcoming years. Emerging economies in this region such as China and India have been experiencing strong economic growth. Increasing living standards have spurred the regional demand. Rising disposable income is expected to trigger the demand for cosmetic procedures in near future. All these factors are anticipated to bode well for regional market growth in the forthcoming years.
The global market is anticipated to witness intense competition over the forecast period. The industry is consolidated in nature and dominated by few players such as Smith & Nephew; Johnson & Johnson; ConvaTec Inc.; Mölnlycke Health Care AB; and Acelity L.P. Inc. The companies adopt strategies such as new product development, geographic expansion via enhancing the distribution network, and merger and acquisitions.
For instance, in January 2017, Derma Sciences, Inc. acquired MEDIHONEY brand from Comvita Limited, a company based in New Zealand, in a probe to increase its advanced wound care product portfolio. In February 2016, Acelity L.P. Inc. entered into a partnership agreement with Mediq for the enhancement of its distribution network for advanced wound care products in Denmark, Norway, Finland, and Sweden. Similar strategic initiatives are expected to fuel competition over the forecast period.
Base year for estimation
Actual estimates/Historic data
2014 - 2017
2019 - 2026
Revenue in USD Million & CAGR from 2019 to 2026
North America, Europe, Asia Pacific, Latin America & MEA
U.S., Canada, U.K., Germany, Italy, France, Spain, Russia, Japan, India, China, Brazil, Mexico, South Africa, Saudi Arabia
Revenue forecast, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global burn care market report on the basis of product, depth of wound, cause of burn, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2026)
Wound Contact Layers
Depth of Wound Outlook (Revenue, USD Million, 2014 - 2026)
Cause Of Burn Outlook (Revenue, USD Million, 2014 - 2026)
End Use Outlook (Revenue, USD Million, 2014 - 2026)
Regional Outlook (Revenue, USD Million, 2014 - 2026)
The Middle East and Africa
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."